Venture's banner year

While the public markets have received most of the attention this year, private biotechs are poised to raise more venture capital in 2014 than in any previous year.

Through the first nine months of 2014, private biotechs worldwide have raised .8 billion, just 0 million shy of the previous annual high of nearly billion in 2007. Since 2000, private biotechs have raised about .3 billion per year, meaning companies this year have already bested that number by almost 30%. ...